期刊文献+

腔镜辅助下McKeown术式切除食管癌507例临床体会 被引量:24

McKeown minimally invasive esophagectomy for the treatment of esophageal cancer: a report of 507 cases
原文传递
导出
摘要 目的总结开展腔镜辅助下McKeown术式切除食管癌的经验体会。方法回顾性分析1997年8月至2012年12月507例施行腔镜辅助下McKeowrt术式切除食管癌的患者临床资料。男348例,女159例;年龄(60.5±10.6)岁。其中,食管肿瘤位于上段39例(7.69%),中段312例(61.54%),下段156例(30.77%),术前放、化疗21例(4.14%)。TNM分期:0期55例(10.85%),瑚167例(32.94%),Ⅱ期203例(40.04%),Ⅲ期69例(13.61%),Ⅳ期13例(2.56%);鳞癌463例(91.32%),腺癌及其他类型44例(8.68%)。手术采用腔镜辅助下经右胸、上腹、左颈人路,其中胸腔镜+开腹281例(55.42%),胸腔镜+腹腔镜179例(35.31%),开胸+腹腔镜32例(6.31%),中转开胸/开腹15例(2.96%)。结果507例患者中腔镜辅助下完成McKeown食管癌切除手术492例(97.04%)。胸腔镜下食管游离及胸腔淋巴结清扫(81.5±34.7)min,腹腔镜下胃游离及腹区淋巴结清扫(60.3±17.5)min。胸腔镜手术出血(105.2±73.1)ml,腹腔镜手术出血(43.5±21.4)ml。清扫淋巴结总数(23.7±11.5)枚/例,其中胸腔淋巴结清扫(14.6±7.7)枚/例,腹腔淋巴结清扫(8.7±5.2)枚/例,颈区淋巴结清扫(1.3±1.1)枚/例。198例经食管床、309例经胸骨后径路重建食管。全组术中无死亡。术中因非病灶原因胸导管损伤13例、心房颤动9例、食管切缘阳性R1切除者3例、奇静脉/脾脏损伤出血3例、电凝钩/超声刀误伤气管3例。术后早期主要并发症为肺部感染54例(10.65%),颈部吻合瘘39例(7.69%),心律失常25例(4.93%),胸腔积液需要置管19例(3.75%),喉返神经损伤17例(3.35%),术后乳糜胸12例(2.37%)。术后早期死亡5例(0.99%)。241例(47.53%)接受术后放化疗。458例随访(41.5±35.9)个月,1、3、5年生存率分别为81.9%(324/396)、53.7%(148/276)、47.6%(63/132)。结论腔镜辅助下MeKeown术式切除食管肿瘤可行、有效,术后近、中期疗效可靠。 [ Abstract] Objective To assess our outcomes after McKeown minimally invasive esephagectomy(MMIE) for the treat- ment of esophageal cancer. Methods From August 1997 to December 2012, MMIE was performed in 507 patients. Esophage- al tumors located in the upper in 39(7.69% ), middle in 312(61.54% ), lower in 156(30.77% ). Preoperative neoadjuvant chemomdiotherapy was used in 21 cases (4.14%). Resection was performed for squamous cancer (463 cases, 91.32% ) , ad- enocareinoma and other histologic types (44 cases, 8.68% ) in patients with stages 0 (55, 10.85% ), I ( 167, 32.94% ) , H ( 203, 40.04% ), ]1I (69, 13.61% ), and IV ( 13, 2.56% ) disease. Surgery were completed by thoracoscopic and lapa- mtomy (281 cases, 55.42% ), total approach( 179 cases, 35.31% ), thoracotomy and laparescopic (32 cases, 6.31% ), conversion to thoracotomy/laparotomy ( 15 cases, 2.96% ). Results MMIE was successfully completed in 492(97.04% ) patients. The operative time of thoracoscopic the esophagus flee and pleural lymph node dissection was(81.5 ±34.7)min(60 - 180 min), laparoseopic stomach free and abdominal area lymphadenectomy was 60.3 ± 17.5) rain(40 - 105 min). The blood loss of thoracoseopic surgery was ( 105.2 ± 73.1 ) ml( 55 - 1080 ml), laparoscopie surgery ( 43.5 ± 21.4 ) ml ( 30 - 350ml). The total number of lymph node dissection was 5 - 48 [ ( 23.7 ± 11.5 )/case ], the number of thoracic lymph node dissection was 3 - 32 [ ( 14.6 ± 7.7 )/case], abdominal lymph node dissection 2 - 29 E ( 8.7 ± 5.2 )/ease)], and neck lymph node dissection 0 -7 [ (1.3 ± 1.1 )/case]. 198 cases of esophageal reconstruction after esophageal bed, 309 cases through the sternum approach. The whole group were no deaths, intraoperative bleeding in 3 cases due to the azygos vein/spleen injury, the hook cautery/ultrasound surgery the knife accidentally injure trachea 3 cases, the non-focal cause 13 cases of thoracic duct injury, 9 cases of atrial llbrillation, esophageal resection margin-positive R1 resection in 3 cases. Major complications in the early postoperative period, lung infection rate was 10.65% (n =54), the neck anasto- mosis leak rate was 7.69% ( n = 39), arrhythmia rate was 4.93% ( n = 25 ), pleural effusion catheter rate was 3.75% ( n = 19 ), recurrent laryngeal nerve injury rate was 3.35% ( n = 17 ), chylothorax rate was 2.37 % ( n = 12). Mortality rate of early postoperative rate was O. 99% ( n = 5 ). 241 patients(47.53% ) received postoperative radiotherapy and chemotherapy. The postoperative group average follow-up time was (41.5 ± 35.9) months( 1 -96 months), a successful follow-up of 458 eases, follow-up rate of 90.3%. The 1-year survival rate was 81.9% ( 324/396), 3-year survival rate was 53.7% ( 148/276), and 5-year survival rate was 47.6% (63/132). Conclusion The surgical and oncologic outcomes of the MMIE procedure for esophageal cancer in our center were acceptable and comparable with those of reported the open-McKeown osophagectomy. The operation was shown to be feasible and safe, and these properties will be consolidated by experience.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2013年第6期334-338,共5页 Chinese Journal of Thoracic and Cardiovascular Surgery
基金 基金项目:浙江省重大科技专项和优先主题项目(2011C13039-2) 浙江省重点科技创新团队项目(2011R09040-03) 浙江省台州市科技局科研项目(091KY04)
关键词 食管肿瘤 腹腔镜 胸腔镜 外科手术 微创性 Esophageal neoplasms Laparoseopas Thoracoscopes Sugical pocedures, minimally invasive
  • 相关文献

参考文献15

  • 1McKeown KC. Total three-stage oesophagectomy for cancer of the oe- sophagus. Br J Surg , 1976, 63:259-262.
  • 2Japanese Society For Esophageal Diseases. Guideline for Clinical and Pathologic Studies on Carcinoma of the esophogus ( ninth edition ). Esophagus, 2004, 1:61-88.
  • 3Luketich JD, Alvelo-Rivera hi, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg, 2003, 238:486-495.
  • 4陈保富,朱成楚,马德华,王春国,吴春雷,林江,张波,孔敏,叶加洪.胸腹腔镜联合手术治疗食管癌81例[J].中华胸心血管外科杂志,2011,27(4):218-220. 被引量:49
  • 5陈保富,朱成楚,王春国,马德华,林江,张波,孔敏.胸腔镜腹腔镜联合手术与开放手术治疗食管癌的同期临床对照研究[J].中华外科杂志,2010,48(16):1206-1209. 被引量:78
  • 6Edge SB, Byrd DR,-Compton CC, et al. AJCC cancer staging manu- al (7th ed). New York, NY:Springer, 2010.
  • 7陈龙奇.制订2009第7版食管癌TNM分期标准[J].中国胸心血管外科临床杂志,2008,15(1):52-55. 被引量:121
  • 8Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R CoU Surg Edinb, 1992, 37:7-11.
  • 9Luketich JD, Schaner PR, Christie NA, et al. Minimally invasive esophagectomy. Ann Thorac Surg, 2000, 70:906-912.
  • 10Yamamoto S, Kawahara K, Maekawa T, et al. Minimally invasive esophagectomy for stage I and II esophageal cancer. Ann Thorac Surg , 2005, 80:2070-2075.

二级参考文献24

共引文献260

同被引文献196

  • 1邵令方,高宗人,卫功铨,许金良,陈明耀,王文光.食管癌和贲门癌外科治疗进展──9107例资料分析[J].中华胸心血管外科杂志,1994,10(1):41-43. 被引量:185
  • 2Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach[J]. J R Coll Surg Edinb, 1992,37 (1) : 7-11.
  • 3Yamamoto S, Kawahara K, Maekawa T, et al. Minimally invasive esophagectomy for stage I and II esophageal cancer[J]. Ann Thorac Surg,2005,80(6) :2070-2075.
  • 4Schwameis K, Ba-Ssalamah A, Wrba F, et al. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center[J]. Anticancer Res, 2013,33 (5) : 2085-2891.
  • 5Zhou J, Chen H, Lu J J, et al. Application of a modified McKeown procedure (thoracoscopic esophageal mobilization three-incision esopbagectomy) in esophageal cancer surgery: initial experience with 30 cases[J]. Dis Esophagus, 2009,22 (8) : 687-693.
  • 6Ben-David K,Sarosi GA,Cendan JC,et al. Technique of minimal- ly invasive Ivor-Lewis esophagogastrectomy with intrathoracic stapled side-to-side anastomosis[J]. J Gastrointest Surg, 2010,14 (10) :1613-1618.
  • 7Pennathur A,Awais O,Luketich JD. Technique of minimally in- vasivc Ivor-Lewis esophagectomy[J]. Ann Thorac Surg, 2010,89 (6) :S2159-2162.
  • 8Bizekis C, Kent MS, Luketich JD, et al. Initial experience with minimally invasive Ivor-Lewis esophagectomy[J]. Ann Thorac Surg, 2006,82 (2) : 402-406.
  • 9Puntamhekar SP, Agarwal GA,Joshi SN, et al. Thoracolaparos- copy in the lateral position for esophageal cancer., the experience of a single institution with 112 consecutive patients[J]. Surg En- dosc,2010,24(10) :2407-2014.
  • 10Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimal- ly invasive esophagectomy: outcomes in 222 patients[J]. Ann Surg,2003,238(4) :486-495.

引证文献24

二级引证文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部